Related scientific articles (all)

Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches.

Authors : De Kock J, Najar M, Bolleyn J, Al Battah F, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Year : 2012
Journal : ALTEX
Volume : 29
Pages : 31-9

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Authors : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Year : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610

Clinical trial design in head and neck cancer: from past experiences to future perspectives.

Authors : de Castro G Jr, Henrique dos Anjos C, Lalami Y, Awada A
Year : 2012
Journal : Clinical Investigation
Volume : 2(5)
Pages : 473-481

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Authors : Ignatiadis M, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1653-5

Euthanasia: from ethical debate to clinical reality.

Authors : Berghmans T, Lossignol D
Year : 2012
Journal : Eur. Respir. J.
Volume : 40(4)
Pages : 804-5

Communication skills training for residents : which variables predict learning of skills?

Authors : Bragard I, Merckaert I, Libert Y, Delvaux N, Etienne AM, Marchal S, Reynaert C, Razavi D
Year : 2012
Journal : Open Journal of Medical Psychology
Volume : 1
Pages : 68-75

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Authors : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Year : 2012
Journal : Breast
Volume : 21(1)
Pages : 20-6

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Authors : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Year : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pages : 21-7

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Authors : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Year : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pages : 14-21

Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Authors : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Year : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pages : 157-68

Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer.

Authors : Berghmans T, Remmelink M, Awada A
Year : 2012
Journal : Lung Cancer : Targets and Therapy
Volume : 3
Pages : 91-99

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Authors : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Year : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28

Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.

Authors : Antoine C, Ameye L, Paesmans M, Rozenberg S
Year : 2012
Journal : Maturitas
Volume : 72(4)
Pages : 317-23

Oncological intensive care: 2011 year's review].

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2012
Journal : Rev Med Brux
Volume : 33(6)
Pages : 540-4

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.

Authors : Awada A, Hendlisz A, Christensen O, Lathia CD, Bartholomeus S, Lebrun F, de Valeriola D, Brendel E, Radtke M, Delaunoit T, Piccart-Gebhart M, Gil T
Year : 2012
Journal : Eur. J. Cancer
Volume : 48(4)
Pages : 465-74

Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.

Authors : Azim H, Azim HA
Year : 2012
Journal : Future Oncol
Volume : 8(2)
Pages : 135-44

Clinical development of insulin-like growth factor receptor-1 (IGF-1R) inhibitors: At the crossroad?

Authors : Gombos A, Metzger-Filho O, Dal Lago L, Awada A
Year : 2012
Journal : Invest New Drugs
Volume : 30(6)
Pages : 2433-42

MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.

Authors : Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, Najar M, Hamade E, Jebbawi F, Merimi M, Romero P, Burny A, Badran B, Martiat P
Year : 2012
Journal : J. Biol. Chem.
Volume : 287(13)
Pages : 9910-22

Second primary cancers in head and neck cancer patients: a challenging entity.

Authors : de Castro G, Awada A
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pages : 203-4